Triveni Bio is a biotechnology company that employs a genetics-informed precision medicine approach to develop functional antibodies targeting immunological and inflammatory disorders. Their proprietary platform focuses on identifying novel therapeutic targets with strong genetic rationale, predicting and stratifying patient subpopulations, and providing insights into disease mechanisms. This strategy aims to establish proof-of-concept early in the drug development process, enhancing the precision and efficacy of treatments.
ZX Index Value | 
To view Pre-IPO pricing data for and trade Triveni Bio, to request access.Aggregate Volume | 
To view Pre-IPO volume data for and trade Triveni Bio, to request access.ZXData is a leading provider of real-time secondary data on private companies. ZXData's dataset incoroporates closed trades with 20bn+ in volume. In addition, it incorporates $200bn+ of buy/sell prices and $70bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.
This report is provided for informational purposes only and does not constitute a recommendation or solicitation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. The values shown in this report are not indicative price quotations. This report does not constitute investment advice, nor does this report constitute a "research report" as defined by FINRA Rule 2241 or a "debt research report" as defined by FINRA Rule 2242.
The ZXData and the information contained in this report, some of which have been obtained from third-party sources, are provided on an "as is" basis and the user of this information assumes the entire risk of any use made of this information. Neither Zanbato Inc. (“Zanbato”) nor its affiliates guarantee the accuracy or completeness of the data contained in this report, or its computation and compilation.
The ZXData and this report constitute Zanbato’s valuable intellectual property. You are expressly prohibited from copying, modifying, transmitting or redistributing the ZXData or this report without Zanbato’s prior written consent.
Go to zanbato.com
